| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-10 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |